What pharma needs to do to keep up with the rise in value-based care.
Jenn Szekely
Advertisement
President, Coley Porter Bell
Articles by Jenn Szekely
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
4
The Risks and Benefits of FDA Reviewing Real-Time Data
5